Regulatory gaps regarding sugars used in injectable biopharmaceuticals

被引：0

作者：

Biere, T ^{[1
]}

机构：

[1] FerroPfanstiehl Labs Inc, Waukegan, IL 60085 USA

来源：

BIOPHARM INTERNATIONAL | 2006年 / 19卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：48 / +

页数：5

共 50 条

[21] REMOVAL AND INACTIVATION OF MODEL VIRUSES BY METHODS COMMONLY USED IN PURIFICATION OF BIOPHARMACEUTICALS
SITO, AF
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 46 - 46
[22] Regulatory compliance under enforcement gaps
Tihitina Andarge
Erik Lichtenberg
Journal of Regulatory Economics, 2020, 57 : 181 - 202
[23] Bridging gaps in the global regulatory framework
Milmo, Sean
Pharmaceutical Technology, 2016, 40 (12) : 8 - 9
[24] Regulatory gaps reported for biotech crops
不详
CHEMICAL & ENGINEERING NEWS, 2003, 81 (18) : 28 - 28
[25] Regulatory roles of sugars in plant growth and development
Ciereszko, Iwona
ACTA SOCIETATIS BOTANICORUM POLONIAE, 2018, 87 (02)
[26] Population health interventions to curb intake of sugars: Gaps in the evidence
Kirkpatrick, Sharon
Maynard, Merryn
Raffoul, Amanda
Stapleton, Jackie
FASEB JOURNAL, 2017, 31
[27] Opinions of French patients with schizophrenia regarding injectable medication
Caroli, Francois
Raymondet, Philippe
Izard, Isabelle
Plas, Joel
Gall, Berengere
Delgado, Antonio
PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 165 - 171
[28] Some Remarks Regarding the Estimation of Critical Gaps
Brilon, Werner
TRANSPORTATION RESEARCH RECORD, 2016, (2553) : 10 - 19
[29] Summary of DIA Workshop: Comparability Challenges: Regulatory and Scientific Issues in the Assessment of Biopharmaceuticals
Lewis, Richard M.
Cosenza, Mary Ellen
DRUG INFORMATION JOURNAL, 2010, 44 (04): : 485 - 504
[30] Compatibility of meropenem with commonly used injectable drugs
Patel, PR
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (23) : 2853 - 2855

← 1 2 3 4 5 →